Mattel Cleans House and Is Looking to Replace CFO
Mattel shares were slipping on Thursday when it came out that the firm is looking to replace its long-standing CFO Kevin Farr. This is definitely another step in reshaping the senior management team.
All Work
Chris Lange
Why This Analyst Sees 20% Upside at Intel
One analyst is suggesting that perhaps Intel has sold off too much from its highs and that maybe it can still milk out plenty of growth.
Social Media Stocks Attract Short Sellers
The June 30 short interest data have been compared with the previous report. Short interest in most of these selected social media stocks increased.
Short Sellers Run for Cover From Cybersecurity Stocks
The June 30 short interest data have been compared with the previous figures, and short interest in most of these selected cybersecurity stocks shrank.
Short Interest in Major Semiconductors Continues to Dip
The June 30 short interest data have been compared with the previous report. Short interest decreased in most of these selected semiconductor stocks.
Short Sellers Hike Bets in Major Biotechs
The June 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Major Pharma Short Sellers Become More Selective
The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Short Sellers Back Off Major Oil
The June 30 short interest data have been compared with the previous figures, and short interest for most of the selected oil stocks decreased.
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was an incredibly positive day for the U.S. markets. Crude oil pushed higher on the day bringing up the Oil & Gas stocks, although there were a couple laggards in the group. For…
Merrill Lynch’s Top 4 Internet Stocks for the Second Half of 2017
Merrill Lynch singled out a group in the tech sector that the firm believes will outperform going forward -- specifically, internet stocks.
Why Jefferies Is Taking a Backseat on IBM
IBM has struggled for year to get out of what some analysts have called a value trap. One analyst is slashing its target for the computer giant and sees further downside for the stock.
Meet the Newest Sports ETF
Sports fans rejoice. There is now an exchange traded fund that caters to this group: the ProSports Sponsors ETF.
Even More Concerns Surface About Apple Ahead of iPhone Launch
Apple reportedly is scrambling to put together its highly anticipated iPhone 8. The company seems to be facing a bug problem with its software. If these bugs persist it could cut into production and…
Why Ocular Therapeutix Shares Are Getting Crushed
Ocular Therapeutix shares were absolutely crushed on Wednesday after the company received less than favorable news from the FDA regarding its Dextenza in the treatment of ocular pain following ophthalmic surgery.
Is Now the Time for This Coal Miner to Come Public?
It is very surprising to see a coal company come forward and file to be publicly traded, considering the industry’s recent history.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a relatively volatile day for the markets seeing the major indices swing between positive and negative a couple times. Crude oil proved to be positive once again and sent most Oil &…
PetIQ Announces Potential Pricing for IPO
PetIQ intends to price more than 5 million shares in the range of $14 to $16 apiece in an initial public offering valued up to more than $104 million.
Meet Jefferies Top 12 Picks in the Roaring Biotech Industry
The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's no wonder that investor interest in this particular industry has grown, and one analyst…
Why Snap’s Value Could Be Headed Even Lower
Camera app company Snap has been the subject of much controversy in the analyst community, with some calling for a turnaround while others are calling for it to sink even lower.
Why Arena Pharmaceuticals Is Knocking It Out of the Park
Shares of Arena Pharmaceuticals saw an incredible gain early Tuesday after the company reported positive results from its mid-stage trial in patients with pulmonary arterial hypertension.